Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models

Cardiorenal Medicine
|January 20, 2012
PubMed

Insights

High salt intake exacerbates hypertensive kidney and heart damage in humans and rats. The renin-angiotensin system (RAS) may mediate these adverse effects, highlighting salt

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Hypertensive disease affects the kidneys and cardiovascular system.
  • Understanding target organ damage in hypertension is crucial.

Purpose of the Study:

  • To review renal and cardiac manifestations of hypertensive disease.
  • To investigate the role of salt and the renin-angiotensin system (RAS) in target organ damage.

Main Methods:

  • Comparison of clinical and experimental studies on hypertensive damage.
  • Analysis of the impact of salt intake and RAS on organ damage.

Main Results:

  • Renal impairment varies in hypertensive patients; minimal in spontaneously hypertensive rats unless salt is high.
  • Cardiac damage is worsened by excess salt in both humans and rats.
  • Evidence suggests RAS mediates adverse effects of salt on heart and kidneys.

Conclusions:

  • Salt intake is a significant factor in hypertensive kidney and cardiac injury.
  • The RAS plays a role in mediating salt-induced target organ damage.
  • Giraffe cardiovascular physiology offers insights into preventing organ damage despite high blood pressure.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...